National institute of biomedical imaging and bioengineering (nibib) innovation funnel commercialization center
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 75N92022D00013
- Awardee
-
National Collegiate Inventors & Innovators Alliance, Inc. UEI D5S9JZ1KDP49
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Task orders
- 16 $112,456,099 obligated
Award facts
- Opportunity
-
- National Institute of Biomedical Imaging and Bioengineering (NIBIB) Innovation Pre-Solicitation · 75N92022R0113 · Posted May 26, 2022
- Combined order value
-
- $112,456,099 Current, with exercised options
- $116,056,099 Potential, with all options
- Last date to order 83% complete
- IDV ceiling 81% used
- $139,562,500.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- Funding agency
- National Institute of Biomedical Imaging and Bioenginering National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541618 Other Management Consulting Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The National Institute of Biomedical Imaging and Bioengineering awarded a single-award indefinite-delivery contract to National Collegiate Inventors & Innovators Alliance, Inc. (doing business as Venturewell) on September 1, 2022, with a ceiling value of $139,562,500 and an ultimate completion date of August 31, 2027. No set-aside applies. Venturewell is a non-profit organization.
Place of performance includes Hadley, Massachusetts (the prime contractor's headquarters) and subordinate performance locations at Frederick, Maryland and Westlake, Maryland for specific delivery orders.
The IDC funds the establishment and operation of Innovation Funnel Commercialization Centers supporting the Rapid Acceleration of Diagnostics (RADx) initiative across multiple public health priorities including COVID-19, monkeypox, HIV/AIDS, endometriosis, maternal health, and cancer screening diagnostics. The contract provides innovation funnel award management, technology evaluation, clinical assessment, and commercialization center operations supporting diagnostic technology development and commercialization.
Recent delivery-order activity under this IDC includes a $29.4 million order issued September 28, 2026, for the RADx Innovation Funnel for Health Technologies Commercialization Center (performance through September 27, 2030); a $9.85 million order issued September 30, 2024, for the RADX Innovation Funnel for Health Technologies Commercialization Center (performance through September 29, 2027); a $5.39 million order issued August 29, 2025, for the NIBIB Innovation Funnel Commercialization Center RADx Blueprint MedTech Translator Cohort 3 (completion May 31, 2027); a $50.5 million order issued March 15, 2023, for the Innovation Funnel for COVID-19 Commercialization Center (completion June 30, 2026); and orders supporting commercialization centers for HIV diagnostics, maternal health, hepatitis C, endometriosis, cancer screening, and monkeypox diagnostics issued between September 2022 and August 2025. All delivery orders are firm fixed-price with no set-aside designation.
Task orders
Show all 16
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Show all 14
Quick answers
Who was awarded contract 75N92022D00013?
75N92022D00013 was awarded to National Collegiate Inventors & Innovators Alliance, Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on September 1, 2022.
How much is contract 75N92022D00013 worth?
Orders under 75N92022D00013 have obligated $112,456,099. Their combined potential value, with all options, is $116,056,099. 75N92022D00013's own ceiling is $139,562,500.
How many orders have been placed under contract 75N92022D00013?
16 orders have been placed under 75N92022D00013, the latest on September 28, 2026.
Which agency awarded contract 75N92022D00013?
National Heart Lung and Blood Institute (National Institutes of Health) awarded 75N92022D00013, with funding from National Institute of Biomedical Imaging and Bioenginering (National Institutes of Health).
Who can order from contract 75N92022D00013?
75N92022D00013 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75N92022D00013 competed?
The extent of competition for 75N92022D00013 was full and open competition. The government received 2 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV